Aqua Metals just had a brutal earnings week — and the stock is still digesting it.
The company reported Q1 2026 results on May 14, and the market was unimpressed. The stock fell 17.8% on the day, extending losses to close at $4.12 by May 15. That leaves AQMS down nearly 15% on the week, even though the one-month view is marginally positive. The print itself showed EPS of -$1.22, a significant improvement from -$10.27 a year ago, yet the market focused on the company's announcement that it was abandoning its Lion Energy acquisition structure while simultaneously signalling a site-selection push for its first commercial lithium recycling facility — a stage-gate shift that raises as many questions as it answers.
Short sellers have been unwinding, not pressing, heading into this catalyst. Short interest in AQMS has fallen sharply over the past month — from above 11% of the free float in early April to 7.1% now, a decline of roughly one-third. The one-week change alone is -13.6%. That is a meaningful retreat for a small-cap name. Earlier in April, when trade-war anxiety was at its peak, shorts built positions to well over 10% of float; they have been steadily covering since mid-April as the macro mood shifted. The ORTEX short score holds at 68, having briefly touched 71.6 in early May, suggesting elevated but not extreme short-side conviction at present.
The lending market tells a more relaxed story. Availability has eased considerably: at 110% of short interest, there are more than enough shares in the pool to meet demand — meaning any incremental short-seller faces no meaningful friction sourcing a borrow. Cost to borrow has also come down, running at 10% APR after spending most of April and early May above 12%. A month ago it was as high as 14.6%. The combination of lower CTB and ample availability suggests the squeeze mechanics that worried longs during the April drawdown have materially faded.
The company has no analyst consensus data that can be considered current — the most recent Benchmark note, which raised its speculative-buy target to $12 from $7, was filed in October 2025, nearly seven months ago. That $12 target is stale relative to a $4.12 stock, and the gap likely reflects how far the narrative has moved since then. Without fresh Street coverage to anchor expectations, the stock is trading predominantly on newsflow and positioning rather than fundamental anchoring.
Insider activity adds a note of caution. The CEO, CFO, and COO all sold shares on April 13 at $3.92 — small in absolute dollar terms (the CEO's sale totalled just over $9,000) but notable as a cluster of simultaneous sells across the full C-suite. A similar trio of sales occurred in February and January. These are consistent with a structured plan-type cadence rather than opportunistic selling, but the pattern has been unidirectional since at least late 2025, with no purchases anywhere in the recent record.
The week ahead now pivots to digesting what the Q1 call revealed. Management described progress on commercialisation across critical minerals and energy storage but dropped the Lion Energy acquisition framework. Correlated Nasdaq peer OMEX fell 11.5% on the week, and SNTG shed 7.4%, suggesting sector-level pressure that compounded AQMS's own specific selloff. The key question the market is now pricing is whether the commercial facility site selection is genuinely advancing or whether the timeline is again being pushed out — and the next operational update, not earnings, will likely provide that answer.
See the live data behind this article on ORTEX.
Open AQMS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
